Literature DB >> 21751324

Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics.

Rob M J Liskamp1, Dirk T S Rijkers, John A W Kruijtzer, Johan Kemmink.   

Abstract

Despite their enormous diversity in biological function and structure, peptides and proteins are endowed with properties that have induced and stimulated the development of peptidomimetics. Clearly, peptides can be considered as the "stem" of a phylogenetic molecular development tree from which branches of oligomeric peptidomimetics such as peptoids, peptidosulfonamides, urea peptidomimetics, as well as β-peptides have sprouted. It is still a challenge to efficiently synthesize these oligomeric species, and study their structural and biological properties. Combining peptides and peptidomimetics led to the emergence of peptide-peptidomimetic hybrids in which one or more (proteinogenic) amino acid residues have been replaced with these mimetic residues. In scan-like approaches, the influence of these replacements on biological activity can then be studied, to evaluate to what extent a peptide can be transformed into a peptidomimetic structure while maintaining, or even improving, its biological properties. A central issue, especially with the smaller peptides, is the lack of secondary structure. Important approaches to control secondary structure include the introduction of α,α-disubstituted amino acids, or (di)peptidomimetic structures such as the Freidinger lactam. Apart from intra-amino acid constraints, inter-amino acid constraints for formation of a diversity of cyclic peptides have shaped a thick branch. Apart from the classical disulfide bridges, the repertoire has been extended to include sulfide and triazole bridges as well as the single-, double- and even triple-bond replacements, accessible by the extremely versatile ring-closing alkene/alkyne metathesis approaches. The latter approach is now the method of choice for the secondary structure that presents the greatest challenge for structural stabilization: the α-helix.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21751324     DOI: 10.1002/cbic.201000717

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  26 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

2.  Design of a selenylsulfide-bridged EGFR dimerization arm mimic.

Authors:  Laura E Hanold; Christopher P Watkins; Norman T Ton; Peter Liaw; Aaron M Beedle; Eileen J Kennedy
Journal:  Bioorg Med Chem       Date:  2015-03-20       Impact factor: 3.641

3.  Modulation of Backbone Flexibility for Effective Dissociation of Antibacterial and Hemolytic Activity in Cyclic Peptides.

Authors:  Alberto Oddo; Thomas T Thomsen; Hannah M Britt; Anders Løbner-Olesen; Peter W Thulstrup; John M Sanderson; Paul R Hansen
Journal:  ACS Med Chem Lett       Date:  2016-05-24       Impact factor: 4.345

4.  1,2,3-Triazole Rings as a Disulfide Bond Mimetic in Chimeric AGRP-Melanocortin Peptides: Design, Synthesis, and Functional Characterization.

Authors:  Srinivasa R Tala; Anamika Singh; Cody J Lensing; Sathya M Schnell; Katie T Freeman; James R Rocca; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-01-18       Impact factor: 4.418

Review 5.  Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs.

Authors:  Natalia Molchanova; Paul R Hansen; Henrik Franzyk
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411

6.  Solid-phase synthesis and evaluation of linear and cyclic ferrocenoyl/ruthenocenoyl water-soluble hexapeptides as potential antibacterial compounds.

Authors:  Johana Gómez; Diego Sierra; Claudia Ojeda; Sugina Thavalingam; Reece Miller; Fanny Guzmán; Nils Metzler-Nolte
Journal:  J Biol Inorg Chem       Date:  2021-07-22       Impact factor: 3.358

7.  Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α.

Authors:  Dennis L Buckley; Jeffrey L Gustafson; Inge Van Molle; Anke G Roth; Hyun Seop Tae; Peter C Gareiss; William L Jorgensen; Alessio Ciulli; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-12       Impact factor: 15.336

8.  Targeting cancer-specific glycans by cyclic peptide lectinomimics.

Authors:  Maria C Rodriguez; Austin B Yongye; Mihael Cudic; Karina Martinez Mayorga; Enbo Liu; Barbara M Mueller; Jon Ainsley; Tatyana Karabencheva-Christova; Christo Z Christov; Mare Cudic; Predrag Cudic
Journal:  Amino Acids       Date:  2017-09-11       Impact factor: 3.520

9.  Targeting tumour proliferation with a small-molecule inhibitor of AICAR transformylase homodimerization.

Authors:  Ian B Spurr; Charles N Birts; Francesco Cuda; Stephen J Benkovic; Jeremy P Blaydes; Ali Tavassoli
Journal:  Chembiochem       Date:  2012-07-04       Impact factor: 3.164

10.  On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions.

Authors:  Jordan V Price; Stephanie Tangsombatvisit; Guangyu Xu; Jiangtao Yu; Dan Levy; Emily C Baechler; Or Gozani; Madoo Varma; Paul J Utz; Chih Long Liu
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.